en 28 Noviembre 2017
Senadora Cuéllar presentó iniciativa en materia de certificación por práctica de ozonoterapia en México

El pasado 12 de Octubre de 2017 se presenta por parte de la Senadora Lorena Cuéllar Sisneros Secretaria de la mesa de dicha cámara, la iniciativa para implementación de la Norma Oficial para Ozonoterapia.




en 28 Noviembre 2017

Concluye exitosamente el 1er Congreso Internacional peruano en Ozonoterapia al que asiste como expositor el Doctor Froylán Alvarado Güémez.

En dicho evento se hace acredor de un reconocimiento especial por su valor, entrega y trabajo en pro de la Ozonoterapia en México y el Mundo.

en 26 Noviembre 2017
10mo. Curso Teórico-Práctico de "Infiltración intradiscal y otras vías de aplicación del ozono en el tratamiento y rehabilitación de las enfermedades del raquis"

 La Asociación Mexicana de Ozonoterapia, AC (AMOZON) conjuntamente con la Sociedad Cubana de Ozonoterapia (SCO), en comunión con la Universidad Autónoma de Sinaloa (UAS), a través del Centro de Investigación y Docencia en Ciencias de la Salud (CIDOCS), llevó a cabo el 10mo. Curso Teórico-Práctico de "Infiltración intradiscal y otras vías de aplicación del ozono en el tratamiento y  rehabilitación de las enfermedades del raquis", que se celebró en la Ciudad de La Habana, Cuba, del 27 de noviembre al 01de diciembre de 2017.

Leer mas
en 26 Noviembre 2017

Pneumocephalus is defined as air in the cranial cavity. Pneumocephalus can result from inadvertent dural puncture during lumbar epidural anesthesia or epidural steroid injection. Presently described is case of 41-year-old woman who had undergone lumbar disc hernia operation but due to ongoing complaints, was diagnosed as having failed back surgery syndrome. Percutaneous epidural neuroplasty was performed. In the operating room, under sterile conditions and under sedoanalgesia, Racz catheter was inserted in caudal area and guided to epidural area with scope. In accordance with Madrid Declaration, 20 ug/mL concentration and 5 mL volume oxygen-ozone mixture was injected. After waiting 5 minutes, 0.25% bupivacaine + 80 mg triamcinolone + 1500 units hyaluronidase was administered through the catheter. After epidural neuroplasty procedure, when patient was taken to gurney, she complained of severe headache and nausea. Computed tomography scans of head were done immediately, and consistent with pneumocephalus, air was observed in right lateral ventricle frontal horn, interhemispheric fissure, and superior cerebellar cistern. Patient was placed in Trendelenburg position and intravenous fluid was replaced. Analgesics and bed rest were recommended as treatment. Patient was discharged from hospital on the second day. Within a week, headache pain and other complaints had resolved. In this article, the case of a failed back surgery patient who was postoperatively treated with medical ozone and experienced complication of pneumocephalus is discussed in context of literature data.

en 26 Noviembre 2017

To compare the effects of bio-oxidative ozone application with occlusal splints in temporomandibular disorder (TMD) patients with pain.



Forty participants were selected after the diagnosis of TMD and randomly divided into two groups: ozone group (OG, n = 20) and occlusal splint group (OCSG, n = 20). Ozone was applied to patients three times per week, for a total of six sessions. Patients in the OCSG were instructed to use occlusal splints every night over a period of four weeks.



Mandibular movements showed significant differences for the time factor in OG and OCSG. Pressure pain thresholds of the temporal and masseter muscles at follow-up were significantly higher in the OCSG group. Both treatments statistically decreased the visual analog scale (VAS) scores. However, no statistically significant difference was observed between groups after the application of treatments.



Occlusal splint treatment is still the gold treatment modality for objective pain relief in patients with TMD pain.



Ozone; occlusal splints; orofacial pain; temporomandibular joint disorders



Más información

en 26 Noviembre 2017

Oxidative stress and inflammation play key roles in the pathogenesis of Multiple sclerosis (MS). Different drugs have been used in the clinical practice, however, there is not a completely effective treatment. Due to its potential therapeutic action, medical ozone represents a promising approach for neurodegenerative disorders. The aim of the present study was to address the role of ozone therapy on the cellular redox state in MS patients. Ozone (20μg/ml) was administered three times per week during a month by rectal insufflation. The effect of ozone therapy on biomarkers of oxidative stress and inflammation was addressed by spectrophotometric and immunoenzymatic assays. Furthermore, we investigated the action of ozone on CK2 expression and Nrf2 phosphorylation by western blotting analysis. Medical ozone significantly improved (P < 0.05) the activity of antioxidant enzymes and increased the levels of cellular reduced glutathione. In accordance, a significant reduction (P < 0.05) of oxidative damage on lipids and proteins was observed in ozone-treated patients. As well, the levels of pro-inflammatory cytokines TNFα and IL-1β were lower after ozone treatment. Ozone therapy incremented the CK2 expression together with Nrf2 phosphorylation in mononuclear cells of MS patients. These findings suggest that ozone´s antioxidant and anti-inflammatory effects might be partially associated with an induction of Nrf2 phosphorylation and activation. These results provide new insights on the molecular events modulated by ozone, and pointed out ozone therapy as a potential therapeutic alternative for MS patients.